Industry News and Articles
Featured post
CALQUENCE Significantly Prolonged the Time Patients Lived Without Disease Progression or Death in Previously Untreated Chronic Lymphocytic Leukemia
AstraZeneca today presented results from the interim analysis of the Phase III ELEVATE TN trial, showing that CALQUENCE® (acalabrutinib) combined with obinutuzumab or as monotherapy significantly improved progression-free survival (PFS)…
Latest posts
Drug Forecasting: The Billion Dollar Sales Dilemma
Ask most early stage pharmaceutical companies about their drugs US sales potential and they will…
Choosing Your Battles: 4 Questions to Ask Yourself When Evaluating Opportunities
“He will win who knows when to fight and when not to fight.” – Sun…
Zev Sunleaf: Breaking Down Barriers and Propagating Partnerships at CHOP
Zev Sunleaf is a recent transplant to CHOP and Philadelphia. Born in Maryland and growing…
Yo, Philly!
Welcome to PhillyBio.com! We conceived of this website when we saw the energy of the…
